Investing in robust surveillance of the effects of covid-19 and future emerging infections in pregnancy should be prioritised

BMJ. 2022 Nov 23:379:o2810. doi: 10.1136/bmj.o2810.
No abstract available

Publication types

  • Editorial

MeSH terms

  • COVID-19*
  • Communicable Diseases, Emerging* / epidemiology
  • Communicable Diseases, Emerging* / prevention & control
  • Female
  • Forecasting
  • Humans
  • Pregnancy